Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture

被引:30
作者
Freedland, CS
Mansbach, RS
机构
[1] Pfizer Inc, Cent Res, Dept Neurosci, Groton, CT 06340 USA
[2] Connecticut Coll, Dept Psychol, New London, CT 06320 USA
关键词
ayahuasca; mice; functional observational battery; harmine; dimethyltryptamine; ethnopharmacology;
D O I
10.1016/S0376-8716(98)00154-9
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Ayahuasca is a psychoactive plant mixture typically composed of the beta-carboline-rich Banisteriopsis caapi vine and the hallucinogenic plant Psychotria viridis. Ayahuasca has long been used by aboriginal populations for its putative spiritual and medicinal benefits. Although the presumed primary chemical constituents of ayahuasca have been identified, little is known about the basic in vivo pharmacology of the extract. Two principal constituents of ayahuasca, the beta-carboline harmine and N,N-dimethyltryptamine (DMT) were selected for detailed study in mice using the Functional Observational Battery (FOB). The B. caapi extract was then examined alone and in combination with DMT. Harmine and the B. caapi extract produced similar effects in the FOE, particularly in the open field. Clonic and tonic motor movements were augmented by DMT administration. Harmine and B. caapi decreased acoustic startle amplitude without significantly affecting prepulse inhibition. DMT appeared to attenuate startle-decreasing effects of harmine and B. caapi, although these effects fell just short of significance. These results suggest that the behavioral effects of B. caapi in mice may be attributed in large part to its principal alkaloid species, harmine, and related beta-carbolines in the extract. Hence, the presence of the banisteriopsis vine in the admixture may directly contribute to the unique subjective effects of ayahuasca. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:183 / 194
页数:12
相关论文
共 33 条
[1]   SOCIOPSYCHOTHERAPEUTIC FUNCTIONS OF AYAHUASCA HEALING IN AMAZONIA [J].
ANDRITZKY, W .
JOURNAL OF PSYCHOACTIVE DRUGS, 1989, 21 (01) :77-89
[2]   MONOAMINE-OXIDASE INHIBITION IN BRAIN AND LIVER PRODUCED BY BETA-CARBOLINES - STRUCTURE-ACTIVITY-RELATIONSHIPS AND SUBSTRATE-SPECIFICITY [J].
BUCKHOLTZ, NS ;
BOGGAN, WO .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (21) :1991-1996
[3]   PLATELET SEROTONIN UPTAKE SITES INCREASED IN DRINKERS OF AYAHUASCA [J].
CALLAWAY, JC ;
AIRAKSINEN, MM ;
MCKENNA, DJ ;
BRITO, GS ;
GROB, CS .
PSYCHOPHARMACOLOGY, 1994, 116 (03) :385-387
[4]   Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca [J].
Callaway, JC ;
Raymon, LP ;
Hearn, WL ;
McKenna, DJ ;
Grob, CS ;
Brito, GS ;
Mash, DC .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1996, 20 (06) :492-497
[5]   NEW CONCEPTS ON MECHANISM OF ACTION OF BENZODIAZEPINES [J].
COSTA, E ;
GUIDOTTI, A ;
MAO, CC ;
SURIA, A .
LIFE SCIENCES, 1975, 17 (02) :167-185
[6]  
De Rios M.Dobkin., 1972, Visionary vine: Hallucinogenic healing in the Peruvian Amazon
[7]  
Gates B., 1982, FLORA NEOTROPICA, V30
[8]   ANTAGONISM OF THE EFFECTS OF THE HALLUCINOGEN DOM AND THE PURPORTED 5-HT AGONIST QUIPAZINE BY 5-HT2 ANTAGONISTS [J].
GLENNON, RA ;
YOUNG, R ;
ROSECRANS, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (2-3) :189-196
[9]   Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil [J].
Grob, CS ;
McKenna, DJ ;
Callaway, JC ;
Brito, GS ;
Neves, ES ;
Oberlaender, G ;
Saide, OL ;
Labigalini, E ;
Tacla, C ;
Miranda, CT ;
Strassman, RJ ;
Boone, KB .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1996, 184 (02) :86-94
[10]  
Harner M.J., 1973, Hallucinogens and shamanism